Sort
326,823 grants matching “clinical trial”
CANCER RESEARCH CENTER OF HAWAII
$1,848,663University Of Hawaii At Manoa · P30 · FY2002 · CA
DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE
$1,848,562Duke University · P01 · FY2001 · AI
SCOR in Pathobiology of Lung Development
$1,848,538Children'S Hospital Of Philadelphia · P50 · FY2002 · HL
NIMH Collaborative HIV/STD Prevention Trial
$1,848,363Research Triangle Institute · U10 · FY2004 · MH
HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC
$1,848,277Michael Agus · Boston Children'S Hospital · U01 · FY2013 · HL
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,848,151Roger L Shapiro · Harvard School Of Public Health · U01 · FY2020 · AI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$1,848,040Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AG
The UCLA Center for In Vivo Imaging in Cancer Biology
$1,847,930Harvey R. Herschman · University Of California Los Angeles · P50 · FY2014 · CA
LONGITUDINAL FOLLOW-UP OF INDIVIDUALS WITH OPIOID USE DISORDER (LFU-OUD). 09/01/2021 - 08/31/2026. N01DA-19-2250. TASK ORDER 75N95021F00007 (TO26).
$1,847,761Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2021 · DA
MD Anderson Cancer Ctr. Gynecology SPORE: Uterine Cancer
$1,847,739Karen Hsieh Lu · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$1,847,715Myron E Essex · Harvard School Of Public Health · U01 · FY2011 · AI
Advancing next-generation CAR-NK therapies targeting CD5 positive T cell malignancies to the clinic
$1,847,485Katy Rezvani · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Topiramate as a Disease Altering Therapy for CSPN
$1,847,422A Gordon Smith · Virginia Commonwealth University · U01 · FY2019 · NS
UNIVERSITY OF CALIFORNIA, IRVINE CANCER CENTER SUPPORT
$1,847,335University Of California Irvine · P30 · FY2000 · CA
Trochanteric Padding to Prevent Hip Fractures
$1,847,262Hebrew Rehabilitation Center For Aged · R01 · FY2002 · AG
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,847,245Ohio State University · P01 · FY2002 · CA
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,847,127Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Aurora NCORP Community Site
$1,847,089Thomas J Saphner · Aurora Health Care, Inc. · UG1 · FY2023 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$1,846,989William M. Sugden · University Of Wisconsin-Madison · P01 · FY2008 · CA
Gene Therapy Pulmonary &Hematologic Disorders
$1,846,928University Of North Carolina Chapel Hill · P01 · FY2005 · HL
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$1,846,796Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
CoVPN Cross-Protocol Analyses
$1,846,794Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Targeting mechanisms of radiation resistance
$1,846,567Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Mechanisms of Normal Tissue Toxicity From Irradiation
$1,846,567Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
PDT Optimization and Mechanisms
$1,846,544Sandra O Gollnick · Roswell Park Cancer Institute Corp · P01 · FY2018 · CA